Deutsche Bank’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-56,188
Closed -$1.35M 4077
2023
Q1
$1.35M Buy
56,188
+17,532
+45% +$220K ﹤0.01% 1913
2022
Q4
$409K Buy
38,656
+4,538
+13% +$36.6K ﹤0.01% 2558
2022
Q3
$153K Buy
34,118
+5,995
+21% +$27.3K ﹤0.01% 3106
2022
Q2
$113K Sell
28,123
-2,362
-8% -$11.2K ﹤0.01% 3471
2022
Q1
$223K Sell
30,485
-11,759
-28% -$70.3K ﹤0.01% 3202
2021
Q4
$237K Sell
42,244
-37,376
-47% -$237K ﹤0.01% 3294
2021
Q3
$509K Buy
79,620
+32,857
+70% +$211K ﹤0.01% 3017
2021
Q2
$394K Sell
46,763
-23,457
-33% -$189K ﹤0.01% 3379
2021
Q1
$737K Buy
70,220
+27,304
+64% +$384K ﹤0.01% 2850
2020
Q4
$727K Buy
42,916
+14,187
+49% +$213K ﹤0.01% 2663
2020
Q3
$368K Buy
28,729
+4,463
+18% +$56.4K ﹤0.01% 2827
2020
Q2
$342K Buy
+24,266
New +$306K ﹤0.01% 2837

Other funds holding PRVB

Deutsche Bank's PRVB Position: Q2 2023 in Review

Deutsche Bank sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 56,188 shares — an estimated $1.35M sold.

Deutsche Bank first reported a position in PRVB in Q2 2020 and held it in 12 quarters. The position peaked at $1.35M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

  • Deutsche Bank reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Deutsche Bank sold 56,188 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $1.35M.
  • Deutsche Bank first reported a position in Provention Bio, Inc. Common Stock in Q2 2020 and held it in 12 quarters.
  • Deutsche Bank's Provention Bio, Inc. Common Stock position peaked at $1.35M in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Deutsche Bank's 13F filing for Q2 2023, filed 14 Aug 2023.